Saturday 17 October 2026
Export ACB’s income statement to Excel — free account
Aurora Cannabis Inc.
ACB Healthcare Drug Manufacturers Specialty & Generic
Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.
3.99
0.11
−2.68%
Follow ACB
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 3 | 4 | 5 | 4 | 4 | — | — | 4 |
P/E ratio |
0.00 | 1,381.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39.91 | 0.00 |
Altman Z-Score |
3.90 | 6.87 | 5.50 | (0.75) | (0.26) | (7.12) | (7.40) | (9.41) | (8.69) | (12.34) |
P/S ratio |
330.36 | 741.08 | 424.53 | 57.79 | 79.86 | 16.22 | 0.98 | 0.93 | 0.98 | 0.80 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
5.15 | 5.00 | 3.86 | (1.65) | (0.98) | (14.31) | (22.93) | (20.09) | (18.86) | (25.83) |
Beneish M-Score |
— | 1.88 | 0.94 | — | — | (11.28) | — | — | (2.59) | (2.53) |
P/Operating CF |
(566.83) | (500.87) | (547.52) | (47.69) | (93.01) | (32.69) | (22.63) | (11.65) | 89.10 | (733.60) |
P/B ratio |
27.20 | 26.17 | 23.98 | 7.58 | 9.61 | 5.42 | 0.50 | 0.42 | 0.55 | 0.50 |
Price to Tangible BV |
40.58 | 70.79 | 198.93 | 20.51 | 25.03 | 6.07 | 0.59 | 0.49 | 0.64 | 0.56 |
EV/Sales |
324.21 | 742.05 | 425.67 | 59.08 | 79.65 | 15.20 | 0.71 | 0.62 | 0.72 | 0.53 |
EV/EBITDA |
305.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.93 | 0.00 |
EV/Operating CF |
0.00 | (378.12) | (278.37) | (26.31) | (44.07) | (17.43) | (0.83) | (2.45) | 15.51 | (12.65) |
EV/FCF |
0.00 | (90.74) | (101.55) | (12.71) | (38.03) | (16.48) | (0.82) | (2.30) | (302.77) | (4.89) |
Quick Ratio |
7.54 | 2.19 | 1.09 | 0.82 | 4.31 | 3.70 | 1.41 | 1.83 | 2.06 | 3.13 |
Current Ratio |
8.25 | 2.92 | 1.52 | 1.54 | 5.72 | 5.13 | 1.98 | 3.42 | 4.31 | 5.94 |
Net Debt/EBITDA |
10.97 | (0.57) | (1.25) | (0.96) | 0.28 | 1.65 | 0.35 | 8.70 | (2.77) | 5.11 |
Debt/Assets |
19.78% | 10.64% | 11.72% | 19.08% | 15.10% | 24.29% | 24.62% | 11.92% | 11.63% | 3.02% |
Debt/Equity |
0.29 | 0.13 | 0.15 | 0.25 | 0.19 | 0.40 | 0.47 | 0.17 | 0.16 | 0.04 |
Asset Turnover |
0.09 | 0.05 | 0.07 | 0.07 | 0.09 | 0.12 | 0.23 | 0.30 | 0.40 | 0.44 |
Operating CF/Net income |
0.81 | (1.14) | 0.66 | 0.10 | 0.30 | 0.06 | 0.44 | 1.04 | 7.06 | 0.11 |
Capex/Depreciation |
(29.87) | (22.49) | (4.69) | (3.06) | (0.34) | (0.13) | 0.00 | (0.13) | (0.64) | (1.19) |
Interest Coverage |
(1.70) | (8.05) | (7.66) | (6.33) | (4.26) | (3.22) | (26.77) | (3.27) | 0.59 | (25.79) |
| (11.52%) | 8.12% | (9.66%) | (100.72%) | (34.17%) | (128.39%) | (44.89%) | (11.98%) | 0.37% | (21.82%) | |
| (6.53%) | 6.48% | (7.76%) | (79.21%) | (26.41%) | (93.92%) | (25.69%) | (7.38%) | 0.26% | (16.82%) | |
ROIC |
(6.47%) | (4.09%) | (4.20%) | (12.33%) | (8.90%) | (33.21%) | 0.00% | (5.60%) | 0.59% | (7.98%) |
Return on Tangible Assets |
(6.01%) | 18.40% | (29.28%) | (302.50%) | (60.15%) | (206.11%) | (47.30%) | (11.00%) | 0.36% | (26.81%) |
Average Days of Receivables |
46.71 | 99.83 | 165.36 | 70.81 | 84.06 | 77.59 | 64.15 | 61.33 | 45.16 | 50.75 |
Research and Development Expense of Revenue |
1.74% | 3.04% | 5.96% | 9.35% | 4.67% | 4.69% | 2.81% | 1.32% | 1.07% | 1.25% |
Selling, General and Administrative Expense of Revenue |
136.53% | 199.04% | 152.74% | 127.80% | 79.46% | 85.39% | 78.61% | 58.04% | 48.49% | 54.12% |
Intangible Assets out of Total Assets |
0.22 | 0.52 | 0.70 | 0.48 | 0.48 | 0.07 | 0.08 | 0.10 | 0.10 | 0.10 |
Share Based Compensation of Revenue |
41.98% | 67.85% | 43.17% | 21.48% | 8.25% | 6.22% | 0.00% | 4.71% | 3.36% | 2.27% |
Graham Net Nets |
0.02 | 0.00 | 0.00 | (0.01) | 0.01 | 0.09 | 0.30 | 0.76 | 0.70 | 1.20 |
Graham Number |
0.00 | 20.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.44 | 0.00 |
Earnings Yield |
(2.32%) | 0.07% | (2.68%) | (102.96%) | (30.48%) | (324.47%) | (44.86%) | (32.48%) | 2.51% | (47.71%) |
Free Cash Flow Yield |
0.00% | (1.10%) | (0.99%) | (8.04%) | (2.62%) | (5.68%) | (87.52%) | (29.12%) | (0.24%) | (13.64%) |
Revenue per Share |
5.86 | 11.35 | 22.13 | 21.49 | 11.32 | 8.14 | 0.54 | 4.64 | 4.50 | 4.09 |
Operating CF per Share |
(3.41) | (16.80) | (17.16) | (26.04) | (9.72) | (4.04) | (0.27) | (1.17) | 0.21 | (0.17) |
Capex per Share |
(10.53) | (56.70) | (36.98) | (27.07) | (1.56) | (0.46) | 0.00 | (0.08) | (0.22) | (0.27) |
Free Cash Flow per Share |
(13.94) | (73.49) | (54.14) | (53.11) | (11.28) | (4.50) | (0.27) | (1.26) | (0.01) | (0.45) |
Cash per Share |
56.64 | 30.72 | 32.32 | 13.04 | 20.52 | 18.02 | 0.70 | 3.14 | 2.44 | 2.10 |
Shareholders Equity per Share |
71.00 | 321.48 | 391.88 | 163.87 | 94.05 | 24.35 | 1.13 | 10.32 | 7.98 | 6.53 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
71.00 | 321.48 | 391.88 | 163.87 | 94.05 | 24.35 | 1.13 | 10.32 | 7.98 | 6.53 |
Free Cash Flow |
(32.39) | (281.47) | (458.12) | (513.88) | (190.79) | (96.71) | (87.08) | (54.25) | (0.59) | (25.30) |
Working Capital |
128.25 | 113.85 | 172.06 | 110.30 | 428.95 | 473.98 | 178.95 | 223.86 | 264.10 | 239.23 |
Capital Expenditures |
(24.47) | (217.14) | (312.92) | (261.90) | (26.42) | (9.93) | (9.12) | (3.47) | (12.09) | (15.52) |
Net Current Asset Value |
67.74 | (100.74) | (338.84) | (176.34) | 77.17 | 255.30 | 53.38 | 140.70 | 168.36 | 223.07 |
EV/EBIT |
324.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.17 | 0.00 |
Capex to Sales |
1.80 | 4.99 | 1.67 | 1.26 | 0.14 | 0.06 | 0.00 | 0.02 | 0.05 | 0.07 |
Price to Operating Income |
330.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 67.69 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.02 | 0.05 | 0.12 | 0.12 | 0.16 | 0.40 | 0.10 | 0.13 | 0.10 | 0.15 |
Cash ROIC |
(9.40%) | (18.65%) | (11.24%) | (24.38%) | (8.50%) | (8.65%) | (11.41%) | (8.27%) | (0.09%) | (5.03%) |
Accounts Receivable Turnover |
7.81 | 6.38 | 3.87 | 3.32 | 4.53 | 4.30 | 5.16 | 6.21 | 7.69 | 7.39 |
Accounts Payable Turnover |
0.37 | 0.70 | 0.87 | 2.50 | 3.58 | 3.15 | 6.24 | 3.43 | 2.32 | 2.97 |
Inventory Turnover |
0.25 | 0.72 | 0.84 | 1.92 | 1.85 | 1.45 | 2.16 | 0.88 | 0.72 | 0.89 |
Average Days of Payables |
1,588.67 | 883.61 | 633.23 | 111.65 | 79.27 | 127.45 | 26.98 | 153.98 | 172.56 | 100.39 |
Days of Inventory on Hand |
2,140.09 | 804.65 | 685.39 | 183.71 | 188.40 | 255.22 | 158.19 | 490.04 | 560.54 | 347.40 |
Average Receivables |
1.74 | 6.82 | 48.37 | 62.59 | 42.22 | 40.63 | 34.00 | 32.25 | 32.09 | 31.39 |
Average Payables |
4.07 | 21.99 | 76.43 | 93.37 | 58.25 | 50.22 | 35.87 | 29.98 | 48.16 | 44.76 |
Average Inventory |
5.99 | 21.46 | 79.51 | 121.12 | 112.38 | 109.03 | 103.77 | 117.58 | 155.00 | 149.28 |
Average Assets |
149.70 | 874.15 | 2,830.68 | 3,115.91 | 2,054.39 | 1,445.00 | 776.50 | 658.97 | 617.26 | 523.94 |
Average Common Equity |
84.83 | 698.15 | 2,273.54 | 2,450.64 | 1,588.06 | 1,056.98 | 444.37 | 405.79 | 441.78 | 403.93 |
Columns are period end dates